Clinical Trial Update: HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

HYPORT is a Phase I/II study evaluating hypofractionated postoperative radiation therapy for squamous cell carcinoma of the head and neck. The trial is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING